Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance
Digital therapeutics (DTx) are innovative therapeutic interventions, in which the therapeutic activity is carried out by algorithms and software. They represent a new opportunity especially for the treatment of chronic pathologies associated with dysfunctional lifestyles and behaviors, where convent...
Saved in:
Main Authors: | Salvatore Crisafulli, Eugenio Santoro, Giuseppe Recchia, Gianluca Trifirò |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Drug Safety and Regulation |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2022.900946/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
by: Salvatore Crisafulli, et al.
Published: (2024-03-01) -
A New Era of Pharmacovigilance: Future Challenges and Opportunities
by: Gianluca Trifirò, et al.
Published: (2022-02-01) -
Navigating Digital Privacy and Surveillance: Post‐Covid Regulatory and Theoretical Insights
by: Karolina Małagocka
Published: (2024-12-01) -
Final Analysis of Post‐Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan
by: Norio Nonomura, et al.
Published: (2025-01-01) -
Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China
by: Xiang Sun, et al.
Published: (2025-12-01)